Therapeutic antibodies in multiple sclerosis.
Goebels
Norbert
N
Neurologische Klinik, Universitätsspital Zürich, Switzerland. norbert.goebels@usz.ch
Becher
Burkhard
B
D000818:Animals; D000906:Antibodies / Q000276:immunology* / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000276:immunology / Q000627:therapeutic use; D007167:Immunotherapy / Q000379:methods* / Q000639:trends*; D018836:Inflammation Mediators / Q000037:antagonists & inhibitors; D023421:Models, Animal; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology* / Q000503:physiopathology; D017211:Treatment Failure
D000906:Antibodies; D000911:Antibodies, Monoclonal; D016756:Immunoglobulins, Intravenous; D018836:Inflammation Mediators